Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Impact of calcium antagonists on bleeding time in patients with chronic renal failure

Journal of Human Hypertension volume 16, pages 199–203 (2002)Cite this article

Abstract

Haemorrhagic diathesis develops in chronic renal failure, in which calcium antagonists are used widely as antihypertensive agents. Although calcium antagonists are reported to impair platelet function, it has not been examined whether calcium antagonists alter bleeding time. The present study was conducted to clarify whether calcium antagonists affect bleeding time in chronic renal failure. Patients with chronic renal failure without and with calcium antagonists were enrolled (n = 156), and bleeding time (Ivy's method) as well as blood parameters (BUN, creatinine, platelet counts, and haemoglobin) were compared in patients with normal and prolonged bleeding time. Among patients not taking calcium antagonists (n = 34), three cases manifested prolonged bleeding time, whereas abnormal bleeding time was observed in 31 patients out of 122. Positive correlations were observed between bleeding time and BUN in both calcium antagonist-untreated (r = 0.46) and -treated groups (r = 0.25). The odds ratio for prolongation of bleeding time in patients taking calcium antagonists was 3.52 (95% CI, 1.01–12.33). In 12 calcium antagonist-treated patients with prolonged bleeding time, the withdrawal of calcium antagonists markedly shortened bleeding time (from 11.3 ± 0.8 to 5.4 ± 0.8 min, P < 0.05, n = 12). In contrast, in the additional group (n = 9), the continued treatment with calcium antagonists had no effect on bleeding time (from 11.7 ± 0.9 to 10.0 ± 1.0 min). Despite the inhibitory effect of calcium antagonists on bleeding time, no clinically serious events associated with haemorrhagic diathesis developed. In conclusion, calcium antagonists prolong bleeding time in patients with chronic renal failure. The subclinical (laboratory) effect of calcium antagonists however is not necessarily associated with haemorrhagic events of clinical significance.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Di Minno G et al. Platelet dysfunction in uremia Am J Med 1985 79: 552–559

    Article  CAS  Google Scholar 

  2. Sagripanti A, Barsotti G . Bleeding and thrombosis in chronic uremia Nephron 1997 75: 125–139

    Article  CAS  Google Scholar 

  3. Takahara K et al. Effects of nifedipine on platelet function Am Heart J 1985 109: 4–8

    Article  CAS  Google Scholar 

  4. Ware JA, Schwartz JB, Horak JK, Solis RT . Inhibition of platelet aggregation by oral dogoxin and reversal with nifedipine J Cardiovasc Pharmacol 1985 7: 262–266

    Article  CAS  Google Scholar 

  5. Johnsson H . Effects by nifedipine on platelet function in vitro and in vivo Thrombosis Res 1981 21: 523–528

    Article  CAS  Google Scholar 

  6. Dale J, Landmark KH, Myhre E . The effects of nifedipine, a calcium antagonist, on platelet function Am Heart J 1983 105: 103–105

    Article  CAS  Google Scholar 

  7. Larsson SO . On coagulation and fibrinolysis in renal failure Scand J Haematol 1971 15: 1–59

    CAS  Google Scholar 

  8. Horowitz HI . Uremic toxins and platelet function Arch Intern Med 1970 126: 823

    Article  CAS  Google Scholar 

  9. Horowitz HI, Stein IM, Cohen BD, White JG . Further studies on the platelet-inhibitory effect of guanidino-succinic acid and its role in uremic bleeding Am J Med 1970 49: 336

    Article  CAS  Google Scholar 

  10. Knight CJM et al. Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function: possible importance for the treatment of unstable angina Circulation 1997 95: 125–132

    Article  Google Scholar 

  11. Zhang X, Hintze TH . Amlodipine releases nitric oxide from canine coronary microvessels: an expected mechanism of action of a calcium channel-blocking agent Circulation 1998 97: 576–580

    Article  CAS  Google Scholar 

  12. Berkels R et al. The calcium antagonist nifedipine stimulates endothelial NO release in therapeutic concentrations Pharm Phamacol Lett 1996 6: 75–78

    CAS  Google Scholar 

  13. Ding Y, Vaziri ND . Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells Hypertension 1998 32: 718–723

    Article  CAS  Google Scholar 

  14. Noris M, Remuzzi G . Uremic bleeding: closing the circle after 30 years of controversies? Blood 1999 94: 2569–2574

    CAS  PubMed  Google Scholar 

  15. Thomas G, Ramwell PW . Identification of guanidino-succinate as a putative endogenous source of the endothelium derived relaxing factor Biochem Biophys Res Commun 1992 183: 584–589

    Article  CAS  Google Scholar 

  16. Todeschini M et al. Guanidino succinate stimulates the release of nitric oxide (NO) from cultured endothelial cells: possible implications for uremic bleeding J Am Soc Nephrol 1998 9: 23A

    Google Scholar 

  17. Remuzzi G et al. Role of endothelium-derived nitric oxide in the bleeding tendency of uremia J Clin Invest 1990 86: 1768–1781

    Article  CAS  Google Scholar 

  18. Pahor M et al. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old Lancet 1996 347: 1061–1065

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by a Grant-in-Aid for Scientific Research (B)-No. 10671004 from the Ministry of Education, Science, Sports and Culture.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan

    K Hayashi, H Matsuda, M Honda, Y Ozawa, H Tokuyama, K Okubo, I Takamatsu, T Kanda, S Tatematsu, K Homma & T Saruta

Authors
  1. K Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Matsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Ozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Tokuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K Okubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I Takamatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Kanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Tatematsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K Homma
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. T Saruta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Hayashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayashi, K., Matsuda, H., Honda, M. et al. Impact of calcium antagonists on bleeding time in patients with chronic renal failure. J Hum Hypertens 16, 199–203 (2002). https://doi.org/10.1038/sj.jhh.1001327

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001327

Keywords

Search

Advanced search

Quick links